The acquisition would strengthen GE HealthCare’s pharmaceutical diagnostics segment by expanding its portfolio in radiopharmaceuticals for PET scans and provide a larger presence in a fast-growing field combining specialized drugs with imaging equipment.
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus (XLV:NYSEARCA)
By Press Room
